OBJECTIVE: The purpose of this study was to determine the de novo dyspareunia rate with the Prolift procedure. STUDY DESIGN: All Prolift cases performed between August 2005 and August 2007 were evaluated. The rate of de novo dyspareunia was calculated by chart review. Type and degree of dyspareunia were assessed by self-administered questionnaire. Demographics, use of hormone therapy, failure rate, and willingness to have the surgery again were summarized using descriptive statistics. RESULTS: The rate of de novo dyspareunia was 16.7%. Over 75% of patients with de novo dyspareunia described the pain as mild or moderate. Most described dyspareunia with insertion. Eighty-three percent of respondents with de novo dyspareunia would have the procedure done again. CONCLUSION: The Prolift is associated with a 17% de novo dyspareunia rate. Despite this, most would have the surgery done again.
OBJECTIVE: The purpose of this study was to determine the de novo dyspareunia rate with the Prolift procedure. STUDY DESIGN: All Prolift cases performed between August 2005 and August 2007 were evaluated. The rate of de novo dyspareunia was calculated by chart review. Type and degree of dyspareunia were assessed by self-administered questionnaire. Demographics, use of hormone therapy, failure rate, and willingness to have the surgery again were summarized using descriptive statistics. RESULTS: The rate of de novo dyspareunia was 16.7%. Over 75% of patients with de novo dyspareunia described the pain as mild or moderate. Most described dyspareunia with insertion. Eighty-three percent of respondents with de novo dyspareunia would have the procedure done again. CONCLUSION: The Prolift is associated with a 17% de novo dyspareunia rate. Despite this, most would have the surgery done again.
Authors: Isuzu Meyer; Gerald McGwin; Thomas A Swain; Mitchell D Alvarez; David R Ellington; Holly E Richter Journal: J Minim Invasive Gynecol Date: 2016-02-23 Impact factor: 4.137
Authors: Bernard Jacquetin; Brigitte Fatton; Claude Rosenthal; Henri Clavé; Philippe Debodinance; Piet Hinoul; Judi Gauld; Olivier Garbin; Juan Berrocal; Richard Villet; Delphine Salet Lizée; Michel Cosson Journal: Int Urogynecol J Date: 2010-08-04 Impact factor: 2.894
Authors: Luisa A Wetta; Kimberly A Gerten; Thomas L Wheeler; Robert L Holley; R Edward Varner; Holly E Richter Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2009-11